Showing 3261-3270 of 4165 results for "".
- OcuCell Announces Funding from the Georgia Eye Bankhttps://modernod.com/news/ocucell-announces-funding-from-the-georgia-eye-bank/2481845/OcuCell, a provider of ocular cell therapy, announce funding from the Georgia Eye Bank. Founded in 1961, Georgia Eye Bank has provided over 60,000 corneas for transplant and is dedicated to improving vision and lives through transplantation of ocular tissue and cells. Fin
- RestoringVision Appoints of Three Directors to its Leadership Teamhttps://modernod.com/news/restoringvision-appoints-of-three-directors-to-its-leadership-team/2481739/Nonprofit RestoringVision announced the appointment of three directors to its leadership team to strengthen its impact in solving the global vision crisis. This follows a year of growth, in which RestoringVision expanded its reach by 48 percent in 2022. In 2023, the organization aims to reac
- National Eye Institute Names Kapil Bharti New Scientific Directorhttps://modernod.com/news/kapil-bharti-is-neis-new-scientific-director/2481726/The National Eye Institute (NEI) has named Kapil Bharti was Scientific Director, effective May 2023. “Dr. Bharti is a world-class translational vision scientist, a thoughtful planner who understands interdisciplinar
- SriniVas R. Sadda, MD, Named 2023-2024 ARVO President Electhttps://modernod.com/news/srinivas-r-sadda-md-named-2023-2024-arvo-president-elect/2481697/Doheny Eye Institute announced that SriniVas R. Sadda, MD, was named President Elect of the Association for Research in Vision and Ophthalmology (ARVO) during its 2023 annual meeting in New Orleans. Dr. Sadda has been a member of ARVO for a number of years, and s
- Luminopia Raises Money to Support Full Commercial Rollout of Amblyopia Therapeutichttps://modernod.com/news/luminopia-raises-money-to-support-full-commercial-rollout-of-amblyopia-therapeutic/2481692/Luminopia announced it has raised an additional $16 million in new capital to support the full commercial rollout later this year of the company’s lead product, Luminopia, a software-based therapeutic for amblyopia, the leading cause of vision loss among children. Luminopia w
- Euclid Announces ABB Optical Group as Licensed Manufacturer and Distributor of Euclid Ortho-K Lenseshttps://modernod.com/news/euclid-announces-abb-optical-group-as-licensed-manufacturer-and-distributor-of-euclid-ortho-k-lenses/2481691/Euclid Vision has announced that ABB Optical Group is now a licensed manufacturer and distributor of the company’s Ortho-K lenses. Financial terms of the deal were not disclosed. ABB, which Euclid says is the largest distributor of soft lenses in the United States,
- UnitedHealthcare Launches Virtual Prescription Renewal Option for Contact Lenses and Glasseshttps://modernod.com/news/unitedhealthcare-launches-virtual-prescription-renewal-option-to-help-members-renew-contact-lenses-and-glasses/2481688/UnitedHealthcare has introduced a new virtual prescription renewal option for the millions of members enrolled in its eligible employer-sponsored vision plans. The renewal option aims to make it more convenient and accessible for plan participants to obtain contact lenses and glasses from th
- Alcon Announces Results of the Alcon Eye On Cataract Surveyhttps://modernod.com/news/alcon-announces-results-of-the-alcon-eye-on-cataract-survey/2481672/Alcon announced the results of the Alcon Eye On Cataract Survey, which was conducted between March and April 2023 in Australia, Brazil, China, Germany, India, Italy, Japan, Spain, South Korea and the United States. The survey set out to evaluate vision and cataract insights among the wo
- FDA Clears CorNeat EverPatch, World's First Non-Degradable, Synthetic Tissue Substitute for Ophthalmic Surgeryhttps://modernod.com/news/fda-clears-corneat-everpatch-worlds-first-non-degradable-synthetic-tissue-substitute-for-ophthalmic-surgery/2481668/The FDA has granted 510(k) clearance to CorNeat Vision's EverPatch, which the company describes as the first synthetic, non-degradable tissue-integrating matrix for use in ophthalmic surgeries. It is composed of a non-woven, polymer matrix which integrates with surrounding tissue an
- Bausch + Lomb Announces Leadership Changeshttps://modernod.com/news/bausch-lomb-announces-leadership-changes/2481644/Bausch + Lomb announced a reshaping of its executive leadership team, including the elevation of all business unit heads. Luc Bonnefoy, senior vice president (SVP), Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision Care; will join the executive management team of the comp